Associate Director, US Portfolio

Select how often (in days) to receive an alert: About Servier Pharmaceuticals: At Servier Pharmaceuticals, we are dedicated to bringing the promise of tomorrow to the patients we serve. We are a commercial stage, privately held pharmaceutical company, based in the U.S. Currently, we have four medicines approved in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML) cholangiocarcinoma (CCA) and Myelodysplastic Syndrome (MDS). We have also accelerated our investment in hard-to-treat cancers, with more than 50% of our research and development dedicated to delivering significant advances in areas of high unmet need that may truly move the needle for our patients. Our pipeline is promising in Oncology and Neuro-Inflammation. About Servier Pharmaceuticals: At Servier Pharmaceuticals, we are dedicated to bringing the promise of tomorrow to the patients we serve. We are a commercial stage, privately held pharmaceutical company, based in the U.S. Currently, we have four medicines approved in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML) cholangiocarcinoma (CCA) and Myelodysplastic Syndrome (MDS). We have also accelerated our investment in hard-to-treat cancers, with more than 50% of our research and development dedicated to delivering significant advances in areas of high unmet need that may truly move the needle for our patients. Our pipeline is promising in Oncology and Neuro-Inflammation. Role Summary The

Associate Director, US Emerging Portfolio Strategy and Performance (US EPSP)

and r

eports into Sr. Director of US EPSP within the Corporate Business Office (CBO) team. US CBO oversees corporate and pipeline strategy, development (business development and alliance management) and operations (PMO office, business excellence and shared operations) among other responsibilities. The Associate

Director US Emerging Portfolio Strategy and Performance

will be

responsible for helping to ensure that US is best positioned to deliver on its strategy and business priorities for emerging products. This person will lead collaboratively through influence and direct, as appropriate, cross-functional project teams and be a trusted advisor/leader. The Portfolio AD is responsible for owning and supporting major Emerging Portfolio Committee workstream deliverables and ensuring the recommendations to the Committee are strategic, clear and actionable. Primary Responsibilities:

Support Senior Director who sets strategic direction of Emerging Portfolio Committee eg. Sets the governance for all in scope deliverables - empowered to approve deliverables for elevation to leadership or request further iteration in collaboration with cross-functional team including US CBO and US R&D COO. Sets meetings, agenda, and required attendance Validates in-scope deliverables and timelines for the Emerging Portfolio Committee which may include

enterprise governance for optimizing our future growth eg LCM, BD, portfolio issues and trade-offs Sets and prioritizes deliverables (e.g., mitigation plans) for the working groups supporting the Emerging Portfolio Committee. Ensures appropriate templates and guidance to bring team members along to succeed Supports the Chair in:

Pressure-testing all deliverables ahead of submissions to global governance. These could include pipeline, LCM and BD assets ahead of DLL, Deal Committee, and other governance venues Providing quarterly updates to US leadership team and as needed for Global teams Analyzing and recommending portfolio tradeoffs ahead of strategic planning cycles

Support or lead new product planning projects pre-commercialization – projects may range from preclinical to Phase 3 Incorporate pipeline/LCM strategy in the US strategic plans for 1, 5, and 10 years Contribute to the development of forward-looking strategies, market positioning and product profiles for pipeline/LCM products by synthesizing primary and secondary inputs that will inform the development and lifecycle plan of products / assets

Collaborate with global teams to provide strategic US market insights (e.g. unmet needs, customer segmentation and insights, target product profile input, market potential, US competitive landscape considerations and risks) Create or support the market entry plan for potential new assets Proactively incorporate key market developments (both scientific and commercial) and changes in competitive landscape for key therapeutic areas/markets into assessment updates Collaborate with functional area experts to develop standardized best practices for all emerging portfolio forecasts & valuation assessments and lead stakeholders effectively

In support of business development activities, may support assessment process for all external in-line and pipeline opportunities for all phases Other duties and responsibilities as assigned Support enablement of a strong culture

of empowerment, accountability, teamwork and mutual trust and respect for Inline team members. Coordinate with Emerging Portfolio Leader to share learnings and raise the bar for the group and organization. CBO Team Success Contribute to success of the CBO team by sharing best practices with other CBO members and support team offsites, events, developing and tracking annual team goals and budgets Support identification of opportunities for improved team effectiveness and collaboration, being an active contributor to the collaborative and transparent team culture. Education and Required Skills:

Undergraduate degree with business, science, or quantitative focus

Graduate degree (MBA, PhD, or similar) a plus

7+ years of work experience in a professional capacity, ideally in strategy consulting and biopharma strategy, BD, new product planning or related roles to be able to pressure test and synthesize deliverables for senior management

Understanding of oncology or rare disease markets and stakeholder perspectives with a proven ability to quickly gain in-depth understanding of various disease states preferred

Strong organizational, managerial and leadership skills (including influence without formal authority) Excellent social competencies, ability to work in highly matrixed organizations effectively Proven experience in developing and delivering client presentations/communications; exceptional written and oral communication skills especially in story telling Strong ability to establish a culture of excellence and motivating groups Ability to work under pressure in fast paced environment and adaptability Experience in developing interpersonal relationships, influencing, and gaining consensus across multiple functions (high EQ) Professional and confident with an ability to work with all levels of the organization, especially senior level leaders. Excellent problem-solving skills, with comfort preparing research and data analysis to support business recommendations Other Relevant Information

:

Boston-area onsite, 2-3 days in the office Travel ~10% of the time for meetings/workshops with Global (Paris), external conferences, and internal meetings/off-sites Servier’s Commitment We’re an organization, committed to modeling diversity, equity, and inclusion for the entire industry, and to maintaining an inclusive environment with equitable treatment for all. We are interested in growing our team with passionate, committed, and innovative individuals. We encourage all to apply to our open roles and are always willing to consider skills and experiences outside of what is listed in the job description.

#J-18808-Ljbffr